Janus Henderson Group PLC Boosts Holdings in Humana Inc. (NYSE:HUM)

Janus Henderson Group PLC grew its stake in Humana Inc. (NYSE:HUM) by 6.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 903,448 shares of the insurance provider’s stock after buying an additional 53,245 shares during the period. Janus Henderson Group PLC owned 0.75% of Humana worth $286,138,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Mendota Financial Group LLC raised its holdings in shares of Humana by 9.2% in the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after buying an additional 27 shares during the last quarter. Capital Advisors Ltd. LLC raised its holdings in shares of Humana by 17.0% in the second quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock worth $80,000 after buying an additional 31 shares during the last quarter. CarsonAllaria Wealth Management Ltd. raised its holdings in shares of Humana by 111.4% in the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after buying an additional 39 shares during the last quarter. Moors & Cabot Inc. raised its holdings in shares of Humana by 2.5% in the third quarter. Moors & Cabot Inc. now owns 1,639 shares of the insurance provider’s stock worth $519,000 after buying an additional 40 shares during the last quarter. Finally, Harbour Investments Inc. raised its holdings in shares of Humana by 10.5% in the second quarter. Harbour Investments Inc. now owns 432 shares of the insurance provider’s stock worth $161,000 after buying an additional 41 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Humana Stock Performance

NYSE:HUM opened at $291.10 on Wednesday. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67. The company’s 50-day moving average price is $274.51 and its 200-day moving average price is $328.34. Humana Inc. has a twelve month low of $213.31 and a twelve month high of $502.73. The company has a market cap of $35.05 billion, a P/E ratio of 25.78, a P/E/G ratio of 2.31 and a beta of 0.53.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. Humana had a net margin of 1.18% and a return on equity of 13.20%. The company had revenue of $29.30 billion for the quarter, compared to the consensus estimate of $28.66 billion. On average, sell-side analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Wall Street Analysts Forecast Growth

HUM has been the subject of several recent research reports. KeyCorp initiated coverage on shares of Humana in a report on Friday, October 11th. They set a “sector weight” rating for the company. Barclays raised their target price on shares of Humana from $250.00 to $253.00 and gave the stock an “equal weight” rating in a report on Thursday, October 31st. Deutsche Bank Aktiengesellschaft reduced their target price on shares of Humana from $349.00 to $250.00 and set a “hold” rating for the company in a report on Thursday, October 3rd. TD Cowen raised their target price on shares of Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a report on Monday, November 4th. Finally, Truist Financial dropped their price target on shares of Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research report on Friday, October 11th. Twenty equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $315.86.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.